Koshinski Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Sell |
9,256
-3,885
| -30% | -$417K | 0.08% | 270 |
|
|
2025
Q1 | $1.33M | Buy |
13,141
+5,665
| +76% | +$571K | 0.11% | 189 |
|
|
2024
Q4 | $668M | Buy |
7,476
+50
| +0.7% | +$4.47M | 0.06% | 312 |
|
|
2024
Q3 | $622K | Buy |
7,426
+56
| +0.8% | +$4.69K | 0.05% | 318 |
|
|
2024
Q2 | $564K | Buy |
7,370
+3,727
| +102% | +$285K | 0.05% | 313 |
|
|
2024
Q1 | $250K | Buy |
+3,643
| New | +$250K | 0.03% | 474 |
|
|
2022
Q2 | – | Sell |
-4,254
| Closed | -$188K | – | 750 |
|
|
2022
Q1 | $188K | Buy |
4,254
+9
| +0.2% | +$399 | 0.02% | 603 |
|
|
2021
Q4 | $180K | Sell |
4,245
-1,513
| -26% | -$64.3K | 0.01% | 654 |
|
|
2021
Q3 | $250K | Buy |
5,758
+106
| +2% | +$4.6K | 0.02% | 547 |
|
|
2021
Q2 | $242K | Buy |
5,652
+50
| +0.9% | +$2.14K | 0.03% | 490 |
|
|
2021
Q1 | $217K | Buy |
5,602
+8
| +0.1% | +$310 | 0.02% | 550 |
|
|
2020
Q4 | $201K | Sell |
5,594
-29
| -0.5% | -$1.04K | 0.03% | 515 |
|
|
2020
Q3 | $236 | Buy |
+5,623
| New | +$236 | 0.03% | 448 |
|
|
2016
Q1 | – | Sell |
-11,367
| Closed | -$210K | – | 225 |
|
|
2015
Q4 | $210K | Sell |
11,367
-3,952
| -26% | -$73K | 0.15% | 199 |
|
|
2015
Q3 | $271K | Sell |
15,319
-732
| -5% | -$12.9K | 0.17% | 171 |
|
|
2015
Q2 | $284K | Sell |
16,051
-1,062
| -6% | -$18.8K | 0.18% | 164 |
|
|
2015
Q1 | $304K | Sell |
17,113
-950
| -5% | -$16.9K | 0.2% | 157 |
|
|
2014
Q4 | $239K | Buy |
+18,063
| New | +$239K | 0.14% | 199 |
|